We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Feasibility of Physical Activity in Advanced Cancer Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00438620
First Posted: February 22, 2007
Last Update Posted: February 25, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Cross Cancer Institute
Information provided by (Responsible Party):
AHS Cancer Control Alberta
  Purpose
Physical activity has been shown to have a positive effect on several quality of life outcomes in cancer patients, but few existing studies have focused on the end stages of cancer. The aim of this pilot study is to test the feasibility of a physical activity intervention in advanced cancer patients, from which data can be used to design a randomized controlled trial if results are encouraging.

Condition Intervention
Advanced Cancer Behavioral: Home-based physical activity program

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Pilot Study to Explore the Role of Physical Activity as a Quality of Life Intervention in Advanced Cancer Patients

Resource links provided by NLM:


Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 30
Study Start Date: October 2006
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Home-based physical activity program
    the role of physical activity as a Quality of Life intervention
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Advanced Cancer Patients
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • able to understand, provide written consent in and speak English
  • cognitive ability to participate
  • clinician-estimated life expectancy between 3 and 12 months
  • approval of treating physician

Exclusion Criteria:

  • any absolute contraindications to physical activity
  • palliative performance scale level of 30% of less
  • any patient within the last days to hour of life
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00438620


Locations
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
AHS Cancer Control Alberta
Cross Cancer Institute
Investigators
Study Chair: Kerry Courneya, PhD AHS Cancer Control Alberta
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: AHS Cancer Control Alberta
ClinicalTrials.gov Identifier: NCT00438620     History of Changes
Other Study ID Numbers: PS-08-0054
First Submitted: February 20, 2007
First Posted: February 22, 2007
Last Update Posted: February 25, 2016
Last Verified: January 2012

Additional relevant MeSH terms:
Neoplasms